Wolverine Trading
SIOX

Wolverine Trading’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Wolverine Trading’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12,100
Closed -$33K – 7255
2021
Q2 		$33K Buy
+12,100
New +$30.1K ﹤0.01% 5658
2021
Q1 		– Sell
-10,700
Closed -$30K – 6565
2020
Q4 		$30K Buy
+10,700
New +$31.2K ﹤0.01% 4671
2020
Q3 		– Sell
-15,900
Closed -$46K – 5371
2020
Q2 		$46K Buy
+15,900
New +$51K ﹤0.01% 4325
2020
Q1 		– Sell
-13,100
Closed -$66K – 5532
2019
Q4 		$66K Buy
13,100
+2,600
+25% +$14.4K ﹤0.01% 4397
2019
Q3 		$69K Buy
+10,500
New +$72.4K ﹤0.01% 3970
2018
Q3 		– Sell
-1,788
Closed -$19K – 6156
2018
Q2 		$19K Hold
1,788
– – ﹤0.01% 5017
2018
Q1 		$19K Sell
1,788
-6,162
-78% -$99K ﹤0.01% 5017
2017
Q4 		$335K Sell
7,950
-4,075
-34% -$183K ﹤0.01% 3467
2017
Q3 		$662K Buy
+12,025
New +$2.03M ﹤0.01% 2310

Other funds holding SIOX

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Wolverine Trading's SIOX Position: Q4 2020 in Review

Wolverine Trading sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q4 2020, closing a stake of 12,491 shares — an estimated $36.4K sold.

Wolverine Trading first reported a position in SIOX in Q3 2017 and held it in 2 quarters. The position peaked at $149K in Q3 2017. 62 funds tracked by Wall St. Rank hold SIOX as of Q4 2020.

  • Wolverine Trading reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Wolverine Trading sold 12,491 Sio Gene Therapies Inc. Common Stock shares in Q4 2020, an estimated $36.4K.
  • Wolverine Trading first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2017 and held it in 2 quarters.
  • Wolverine Trading's Sio Gene Therapies Inc. Common Stock position peaked at $149K in Q3 2017.
  • 62 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q4 2020.

Based on Wolverine Trading's 13F filing for Q4 2020, filed 12 Feb 2021.